Baystate Health to develop AI tools that match patients to clinical trials

Boston-based Baystate Health launched new efforts to develop artificial intelligence tools that will help advance innovations in radiology, neurology and oncology, according to a Nov. 12 news release.

Within the health system's innovation arm TechSpring, clinicians will work to evaluate AI solutions that are designed to improve speed and accuracy in diagnosing blood clots in stroke patients. Additionally, Baystate Health seeks to improve clinical pathways for physicians treating and diagnosing patients. TechSpring will also leverage AI to help physicians identify potential patient matches to oncology clinical trials.

Baystate Health has teamed up with Life Image to develop the AI tools. The two organizations have been working together for nearly 10 years. TechSpring was launched five years ago to accelerate innovation across the health system.

"Baystate Health and TechSpring are excited to partner with Life Image on the next generation of healthcare technology with AI initiatives that have targeted use cases with high clinical utility and value," said Richard Hicks, MD, department chair of radiology at Baystate. "For example, by understanding how similar patients may have been diagnosed or treated can help improve accuracy and, ultimately, patient outcomes."

More articles on AI:
Viewpoint: AI should be used not just to predict disease, but to understand the underlying causes
Why AI is being used more in clinical workflows, quality reports
To get executives on board with new tech, put ROI before AI

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers